Skin Cancer

Melanoma survivors may have an increased risk of recurrence, which may heighten fear and worry, but “it’s OK and normal to be worried,” a doctor said.

From Fortnight player, “Ninja” announcing his melanoma diagnosis to an LSU quarterback sporting the name of his teammate with brain cancer, here’s what’s going on in the oncology space this week.

Even the difficult experiences that we share, like the emotional and physical discomfort that comes with a cancer scan, can be a little easier when we know someone else has been through them, too.

From Richard Simmons discussing his skin cancer to Nicole Eggert shaving her head, here’s what’s happening in the oncology space this week.

Patients who underwent breast cancer radiation had higher rates of skin cancer, although altering their treatment plan is unnecessary, an expert said.

From Oliva Munn and Christine Brinkley discussing their cancer to Donnie Iris returning to the stage after his experience with the disease, here is what’s happening in the oncology space this week.

From Jason Kelce honoring the team trainer who has been diagnosed with cancer to deaths in the sports reporting and music world, here’s what’s happening in the oncology space this week.

The Food and Drug Administration approved Amtagvi, a TIL therapy, for patients with advanced melanoma whose disease progressed on or after a checkpoint inhibitor and targeted therapy.

From the San Francisco 49ers’ Trent Williams looking back on his cancer experience to a Republican congressman returning to work after myeloma treatment, here’s what’s happening in the oncology space this week.

Substance use disorders, such as alcohol use disorder, were found to be more prevalent among survivors of specific cancer types, according to research.

Some with metastatic cancers receiving end-of-life-initiated immunotherapy may have a decreased risk of mortality when treated at a high-volume facility, research found.

Vd1-gd T cells, a rare type of immune cell, have been found to potentially predict how likely it is that certain patients with advanced skin cancer will be responsive to treatment via immunotherapy, according to recently published research.

A patient in a phase 2 trial has received the first dose of a novel cancer vaccine plus Keytruda for solid skin cancer tumors.

As Billy Bean, MLB VP, revealed a cancer diagnosis and Toronto Blue Jays sportscaster, Jamie Campbell showed pre-skin cancer photo, here is what’s happening in the oncology space this week.

The Food and Drug Administration gave the green light to a phase 1/2 trial of KSQ-001EX for patients with melanoma, head and neck squamous cell carcinoma and non-small cell lung cancer.

The FDA approved Opdivo for the treatment of patients aged 12 years and older with stage 2B or 2C melanoma that has been surgically removed

There are many immunotherapy-caused skin toxicities, though most can be easily managed.

Mohs micrographic surgery offered better survival outcomes for patients with early-stage Merkel cell carcinoma, compared with wide local excision.

"Margaritaville" singer-songwriter Jimmy Buffett died four years after receiving a diagnosis of Merkel cell carcinoma that "can be really nasty," one expert tells CURE.

‘Margaritaville’ singer-songwriter Jimmy Buffett had received a diagnosis of skin cancer followed by lymphoma four years ago, according to TMZ.

It’s been a long road since being diagnosed with melanoma in early 2020.

The Hepzato Kit is a direct-to-liver therapy for patients with uveal melanoma with hepatic metastases.

Patients with advanced Merkel cell carcinoma treated with Opdivo had improved disease-free survival rates compared with those who underwent observation.

A recent study documented the benefits of maintaining normal vitamin D levels for patients with inoperable, locally advanced or metastatic melanoma receiving anti-PD-1 immunotherapy.

A global trial recently launched that will investigate a personalized mRNA vaccine with Keytruda for patients with skin cancer.

Treatment with a CAR-M cell therapy plus Keytruda is being assessed in a phase 1 study in patients with HER2-overexpressed tumors.

The TILVANCE-301trial, expected to be completed in 2030, is the latest study of what has been described as one of the “phenomenal discoveries in melanoma.”

After two years of follow-up, patients with advanced melanoma treated with Opdivo and Opdualag continued to obtain a survival benefit compared with Opdivo alone.

Here’s an overview of the new cancer regimens that gained Food and Drug Administration (FDA) approval in the spring of this year.